AKT1 and neoplasm: In the presence of transforming growth factor-β, the PD-1-pathway-mediated downregulation of Akt/mTOR signaling induces Treg cell development, resulting in the augmentation of immunosuppressive conditions in tumor-bearing hosts [31].